Skip to content

The acute effects of coffee extract on cognitive function and mood in healthy older adults

The acute effects of coffee extract on cognitive function and mood in healthy older adults

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000067976
Enrollment
60
Registered
2011-01-19
Start date
2010-11-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Participants come for one practice visit where they go through the screening questions and provide informed consent. They also practice on all cognitive and mood tasks they will be doing on their subsequent testing sessions. Participants come for 3 testing sessions at least 1 week apart. At each testing session, they first complete baseline 'mood, cognitive, mood' assessments and doppler ultrasound followed by treatment administration. They complete 'mood, cognitive mood' assessment at 40mins and 120mins post dose and doppler at 90mins post dose

Interventions

Participants each consume one dose of each of the 3 treatments: coffee (6g), coffee extract (540mg), placebo at least 1 week apart. All treatments are powder form and mixed with water (with milk/saccharin as desired)

Sponsors

Nestec
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
50 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

*Age 50 and over *Healthy (i.e. absence of all exclusion criteria) older male and female adults *Light to moderate coffee drinkers (i.e. with caffeine) *Drink no more than 8 cups of coffee per week *Participants must abstain from caffeine-containing foods/beverages and alcohol for 24 hours prior to the training session and each testing session. *Written informed consent obtained

Exclusion criteria

*Existing or pre-existing physical or neurological conditions *History of psychiatric, cardiac, endocrine, gastrointestinal, or bleeding disorders *Clinically high blood pressure *Under treatment with spironolactone-like anti-diuretics, aldosteron-receptors antagonists or angiotensin II- antagonists *Hearing impairment *Psychoactive medications *History of substance abuse *Smoker *Food allergies *Potassium reduced diet *Score <24 on the Mini-Mental State Exam *Currently participating or having participated in another clinical trial during the last 2 months prior to the beginning of this study

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 10, 2026